Peter W. Andrew

16.4k citations

229 papers · 12.3k indexed · 2 hit papers · h-index 64

Impact in

Microbiology top 0.05%
- Bacterial Infections and Vaccines
Epidemiology top 0.2%
- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Pneumocystis jirovecii pneumonia detection and treatment

Papers in

Microbiology 36
- Bacterial Infections and Vaccines 33
Epidemiology 134
- Pneumonia and Respiratory Infections 104
- Respiratory viral infections research 29
- Pneumocystis jirovecii pneumonia detection and treatment 20
- Mycobacterium research and diagnosis 20

Co-authors: Timothy J. Mitchell Aras Kadioglu James C. Paton Jeffrey N. Weiser G J Boulnois Hasan Yeşilkaya Robert J.C. Gilbert Maria Leonor Faleiro
Journals: Infection and Immunity (40 papers)Molecular Microbiology (8 papers)Scientific Reports (7 papers)Microbial Pathogenesis (7 papers)PLoS Pathogens (6 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

Peter W. Andrew

228 papers receiving 12.0k citations

Hit Papers

align trajectories log scale

The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease 2008 · 865 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Nature Reviews Microbiology
1999 Cardiovascular Research

Peers

Countries citing papers authored by Peter W. Andrew

Since Specialization

Citations

This map shows the geographic impact of Peter W. Andrew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Andrew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Andrew more than expected).

Fields of papers citing papers by Peter W. Andrew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Andrew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Andrew. The network helps show where Peter W. Andrew may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter W. Andrew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter W. Andrew Line = papers co-authored together Peter W. Andrew links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characterization and Stability of Spray Dried Plasma Manufactured with the Frontlineodp™ System Blood ·Peter W. Andrew, L. J. Buckley, Mark A. Popovsky, 勝高津, Leonard B.Seeff	2024	0
2	Environmental and genetic regulation of Streptococcus pneumoniae galactose catabolic pathways Nature Communications ·G. Ribbink, 陈阿明, R. Kim, Se-Ryoung Kim, T. Wünsche, Marco R. Oggioni, Peter W. Andrew, Andrew T. Ulijasz, N. Luisa Hiller, Hasan Yeşilkaya	2024	5
3	Splenic macrophages as the source of bacteraemia during pneumococcal pneumonia EBioMedicine ·David Carreño, Joseph J. Wanford, Gheorghe Racoviţă, N Maass, Wen Yuan Chung, Ashley R. Dennison, Kees R. Straatman, Luisa Martı́nez-Pomares, Manish Pareek, Carlos J. Orihuela, Marcos I. Restrepo, Wei Shen Lim, Peter W. Andrew, E. Richard Moxon, Marco R. Oggioni	2021	13
4	The B-cell inhibitory receptor CD22 is a major factor in host resistance to Streptococcus pneumoniae infection PLoS Pathogens ·Vitor E. Fernandes, Giuseppe Ercoli, Alan Bénard, Carolin Brandl, Hannah Fahnenstiel, Jennifer Müller, Georg F. Weber, Paul Denny, Lars Nitschke, Peter W. Andrew	2020	7
5	Phase variation in pneumococcal populations during carriage in the human nasopharynx Scientific Reports ·Megan De Ste Croix, Elena Mitsi, Andrew Morozov, Cristina Parisi, Peter W. Andrew, Daniela M. Ferreira, Marco R. Oggioni	2020	5
6	Intracellular replication of Streptococcus pneumoniae inside splenic macrophages serves as a reservoir for septicaemia Nature Microbiology ·Giuseppe Ercoli, Vitor E. Fernandes, Wen Yuan Chung, Joseph J. Wanford, Sarah Thomson, Christopher D. Bayliss, Kees R. Straatman, Paul R. Crocker, Ashley R. Dennison, Luisa Martı́nez-Pomares, Peter W. Andrew, E. Richard Moxon, Marco R. Oggioni	2018	96
7	Listeria monocytogenes has both a bd-type and an aa3 -type terminal oxidase which allow growth in different oxygen levels and both are important in infection White Rose Research Online (University of Leeds, The University of Sheffield, University of York) ·David F. Corbett, Marie Goldrick, Vitor E. Fernandes, Sandra T. Davidge, Robert K. Poole, Peter W. Andrew, Jim Cavet, Ian S. Roberts	2017	18
8	Pneumococcal 6-Phospho-β-Glucosidase (BglA3) Is Involved in Virulence and Nutrient Metabolism Infection and Immunity ·Vanessa S. Terra, Xiangyun Zhi, حسن حمد عبدالله, Peter W. Andrew, Hasan Yeşilkaya	2015	15
9	The In Vivo Environment Accelerates Generation of Resuscitation-Promoting Factor–Dependent Mycobacteria American Journal of Respiratory and Critical Care Medicine ·Obolbek Turapov, Sarah Glenn, Bavesh D Kana, Vadim Makarov, Peter W. Andrew, Galina V. Mukamolova	2014	18
10	Septicaemia models using Streptococcus pneumoniae and Listeria monocytogenes: understanding the role of complement properdin Medical Microbiology and Immunology ·Aline Dupont, Porcari Andrea, Lourdes Aguila, Sarah Glenn, 柳宏才, Jeder Herausforderung, Simon Byrne, Mariyatul Qibthiyah, García Rueda Muñoz, 導彦中村, Petya Dimitrova, Wilhelm Schwaeble, Nina Ivanovska, Aras Kadioglu, Lee R. Machado, Peter W. Andrew, Cordula Stover	2014	13
11	Development of a rapid DNA extraction method and one-step nested PCR for the detection of Naegleria fowleri from the environment Water Research ·Arine Fadzlun Ahmad, James Lonnen, Peter W. Andrew, Simon Kilvington	2011	15
12	Human Lung Mast Cells Mediate Pneumococcal Cell Death in Response to Activation by Pneumolysin The Journal of Immunology ·Glenn Cruse, Vitor E. Fernandes, L Zwolak, F. E. MCLAUGHLIN, H. V. R. Silva, Mariyatul Qibthiyah, Peter W. Andrew, Peter Bradding, Aras Kadioglu	2010	37
13	Identification of a detrimental role for NK cells in pneumococcal pneumonia and sepsis in immunocompromised hosts Microbes and Infection ·A. Kerr, Lea‐Ann S. Kirkham, Aras Kadioglu, Peter W. Andrew, Paul Garside, Boahua Li, Timothy J. Mitchell	2005	45
14	Streptococcus pneumoniae -Induced Inhibition of Rat Ependymal Cilia Is Attenuated by Antipneumolysin Antibody Infection and Immunity ·Robert A. Hirst, MG GROLLINO, Timothy J. Mitchell, Peter W. Andrew, Christopher O’Callaghan	2004	22
15	The innate immune response to pneumococcal lung infection: the untold story Trends in Immunology ·Aras Kadioglu, Peter W. Andrew	2004	127
16	Streptococcus pneumoniaeproduces a second haemolysin that is distinct from pneumolysin Microbial Pathogenesis ·James Canvin, James C. Paton, Graham J. Boulnois, Peter W. Andrew, Timothy J. Mitchell	1997	10
17	Distinct Roles for Pneumolysin's Cytotoxic and Complement Activities in the Pathogenesis of Pneumococcal Pneumonia American Journal of Respiratory and Critical Care Medicine ·Jeffrey B. Rubins, Darlene Charboneau, C E Fasching, Anne M. Berry, James C. Paton, Janet E. Alexander, Peter W. Andrew, Timothy J. Mitchell, Edward N. Janoff	1996	82
18	In Vitro Interaction of Mycobacterium tuberculosis and Macrophages: Activation of Anti-mycobacterial Activity of Macrophages and Mechanisms of Anti-mycobacterial Activity Current topics in microbiology and immunology ·Lyn M. O’Brien, Barrie Roberts, Peter W. Andrew	1996	19
19	Guinea-pig alveolar macrophage killing of Mycobacterium tuberculosis, in vitro, does not require hydrogen peroxide or hydroxyl radical Microbial Pathogenesis ·유문용, Peter W. Andrew	1991	9
20	Guinea-pig alveolar macrophages kill Mycobacterium tuberculosis in vitro, but killing is independent of susceptibility to hydrogen peroxide or triggering of the respiratory burst Microbial Pathogenesis ·유문용, P. S. Jackett, Douglas B. Lowrie, Peter W. Andrew	1991	25

About Peter W. Andrew

Peter W. Andrew is a scholar working on Microbiology, Epidemiology, Biotechnology, Infectious Diseases and Immunology, having authored 229 papers that have together received 12.3k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (104 papers), Bacterial Infections and Vaccines (33 papers), Respiratory viral infections research (29 papers), Streptococcal Infections and Treatments (26 papers), Listeria monocytogenes in Food Safety (23 papers), Tuberculosis Research and Epidemiology (22 papers), Pneumocystis jirovecii pneumonia detection and treatment (20 papers) and Mycobacterium research and diagnosis (20 papers). The work is most often cited by research in Microbiology (2.4k citations), Epidemiology (5.8k citations), Biotechnology (970 citations), Immunology (2.0k citations) and Infectious Diseases (1.7k citations). Peter W. Andrew has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Timothy J. Mitchell, Aras Kadioglu, James C. Paton, Jeffrey N. Weiser, G J Boulnois, Hasan Yeşilkaya, Robert J.C. Gilbert, Maria Leonor Faleiro, Ian S. Roberts and Robert A. Hirst. Their work appears in journals such as Infection and Immunity, Molecular Microbiology, Scientific Reports, Microbial Pathogenesis and PLoS Pathogens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact